Skip to main content
. 2026 May 26;8(3):232–252. doi: 10.36519/idcm.2026.903

Table 2.

Comparative clinical and veterinary syndromes of zoonotic NTM.

Host domain Typical syndromes Key NTM species Zoonotic relevance AMR concern
Humans Chronic pulmonary disease, post-TB lung infection M. abscessus,MAC Shared environmental/animal sources High;M. abscessuswitherm41-mediated macrolide resistance
Cutaneous/soft tissue (“fish tank granuloma”) M. marinum, M. fortuitum, M. chelonae Direct exposure via fish/aquaculture or contaminated wounds Moderate; resistant isolates increasingly reported
Disseminated infections (immunocompromised hosts) M. intracellulare, M. kansasii Often environmental, sometimes zoonotic link Variable; multidrug resistance in select isolates
Veterinary Subclinical colonization; granulomatous lesions in cattle/swine M. aviumsubsp.hominissuis,M. intracellulare Farm-to-human transmission documented Moderate; overlapping resistance with human isolates
Camel nasal/milk isolates in arid zones M. fortuitum, M. intracellulare Occupational and dairy-related zoonotic risk Emerging; limited data but resistant strains reported
Companion animal cutaneous/disseminated disease M. fortuitum, M. chelonae, M. abscessus Direct zoonotic exposure via pets High; resistant strains comparable to human infections

NTM: nontuberculous mycobacteria, AMR: Antimicrobial resistance, TB: Tuberculosis, MAC: Mycobacterium avium complex.